These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Nishikai M; Tomomatsu S; Hankins RW; Takagi S; Miyachi K; Kosaka S; Akiya K Rheumatology (Oxford); 2001 Jul; 40(7):806-10. PubMed ID: 11477286 [TBL] [Abstract][Full Text] [Related]
37. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Huth TK; Staines D; Marshall-Gradisnik S J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723 [TBL] [Abstract][Full Text] [Related]
38. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Morrison LJ; Behan WH; Behan PO Clin Exp Immunol; 1991 Mar; 83(3):441-6. PubMed ID: 1706238 [TBL] [Abstract][Full Text] [Related]